Why Teva Pharma (TEVA) Should Settle With Novartis - Leerink
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
GenVec (GNVC) Says Novartis (NVS) Remains Committed to CGF166 Amid Internal Changes
September 1, 2016 7:43 AM EDTGenVec (Nasdaq: GNVC) disclosed the following in a U.S. SEC filing on Thursday:
Item 7.01. Regulation FD Disclosure.
On August 31, 2016, press reports disclosed that Novartis (NYSE: NVS) is planning to eliminate its... More
